Spinal Muscular Atrophy (SMA)

We continue to partner with the spinal muscular atrophy (SMA) community to improve the lives of those living with SMA.

Challenge

SMA is an autosomal recessive genetic disorder caused by reduced levels of SMN protein throughout the body, resulting from mutations in the survival motor neuron-1 (SMN1) gene. It affects approximately 1 in 10,000 babies born worldwide each year and is the most common genetic cause of death in infants.

It is a disease that robs people of their physical strength by affecting motor nerve cells, taking away the ability to walk, eat and even breathe.

Focus

We have been inspired by the SMA community throughout our ten-year history of research and investigation into the SMA. Working together, we continue to strive for further understanding and progression of the science behind SMA.

More cases of Neuroscience

M-NZ-00000733/MR9617/SEP2023

© 2024, Roche Products (New Zealand) Ltd, Auckland. This site is intended for New Zealand audiences. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or use in the country of your origin. Access to this site is subject to the terms in our Legal and Privacy Statement. You accept these terms by continuing to access this site.

M-NZ-00000625-v10.0/MR10379/MAY24. This site was last updated MAY2024

ContactDrug SafetyWorldwide LocationslinkedinfacebooktwitterinstagramyoutubePharma solutionsRoche careersRoche cancer treatmentsRoche diagnosticsRoche hubPrivacy statementLegal statementContact UsHealthcare Professionals Portal